1012 Results for "

HDAC

" in MedChemExpress (MCE) Product Catalog:
Products (1012)

1012 Results for "HDAC" in MCE Product Catalog:

  • Categories Recommended:
    More
5
5 Cited Publications
Cat. No.: HY-111556
CAS No.: 2361493-16-3
Purity:  ≥98.0%
Target:  

PROTACs CDK Apoptosis

Research Areas:  

Cancer

BSJ-03-123 is a selective PROTAC degrader of CDK6. BSJ-03-123 degrades CDK6, thereby inhibiting Rb S780 phosphorylation and inducing G1 phase arrest, while remodeling cell cycle and transcriptional signaling, with no effect on CDK4-dependent cancer cells. BSJ-03-123 reduces CDK6 protein levels in mouse ovarian tissues, increases the proportion of primordial follicles, and induces granulosa cell apoptosis, without impairing the ability of oocytes to resume meiosis and mature to the MII stage. BSJ-03-123 alleviates uveitis by blocking the HDACs-CDK6/ID2 axis. BSJ-03-123 can be used in studies related to acute myeloid leukemia, mantle cell lymphoma and autoimmune uveitis .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-111342
CAS No.: 1417997-93-3
Purity:  99.77%
Target:  

HDAC

Research Areas:  

Cancer

HDAC8-IN-1 is a HDAC8 inhibitor with an IC50 of 27.2 nM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13265
CAS No.: 935881-37-1
Purity:  98.52%
Synonyms: HDAC-42; OSU-HDAC42
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

AR-42 (HDAC-42; OSU-HDAC42) is a potent, orally bioavailable pan-HDAC inhibitor (IC50=16 nM). AR-42 induces growth inhibition, cell-cycle arrest, apoptosis, and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 shows cytotoxicity against various human cancer cell lines .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100748
CAS No.: 934828-12-3
Purity:  99.81%
Synonyms: CXD101
Target:  

HDAC

Research Areas:  

Cancer

Zabadinostat (CXD101) is a potent, selective and orally active class I HDAC inhibitor with IC50s of 63 nM, 570 nM and 550 nM for HDAC1, HDAC2 and HDAC3, respectively. Zabadinostat has no activity against HDAC class II. Zabadinostat has antitumor activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15994
CAS No.: 1316215-12-9
Synonyms: ACY241
Target:  

HDAC

Research Areas:  

Cancer

Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18712
CAS No.: 926259-99-6
Target:  

HDAC Apoptosis Caspase

Research Areas:  

Cancer

BG45 is a potent HDAC3 inhibitor with IC50 values of 0.289, 2, 2.2 and ﹥20 μM for HDAC3, HDAC1, HDAC2 and HDAC6, respectively. BG45 selectively targets multiple myeloma (MM) cells and induces caspase-dependent apoptosis .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13267
CAS No.: 99873-43-5
Purity:  98.91%
Synonyms: NS 41080
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Droxinostat (NS 41080) is a histone deacetylase (HDAC) inhibitor. Droxinostat selectively inhibits HDAC3, HDAC6, and HDAC8 with IC50 values of 16.9 μM, 2.47 μM, and 1.46 μM, respectively. Droxinostat can be used for the research of hepatocellular carcinoma (HCC) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-16012
CAS No.: 1186222-89-8
Synonyms: 4SC-202
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Domatinostat tosylate (4SC-202) is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-16012A
CAS No.: 910462-43-0
Synonyms: 4SC-202 free base
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112719
CAS No.: 315698-07-8
Purity:  99.66%
Target:  

HDAC

Research Areas:  

Cancer

BRD 4354 is a moderately potent inhibitor of HDAC5 and HDAC9, with IC50s of 0.85 and 1.88 μM, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15489
CAS No.: 287383-59-9
Purity:  98.09%
Synonyms: Scriptide; GCK1026
Research Areas:  

Cancer

Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N2609
CAS No.: 2196-14-7
7,4'-Dihydroxyflavone (7,4'-DHF) is a flavonoid, which can be isolated from Glycyrrhiza uralensis. 7,4'-Dihydroxyflavone is eotaxin/CCL11 inhibitor and CBR1 inhibitor (IC50=0.28 μM). 7,4'-Dihydroxyflavone has the ability to consistently suppress eotaxin production and prevent dexamethasone (Dex)‐paradoxical adverse effects on eotaxin production . 7,4'-Dihydroxyflavone (7,4'-DHF) inhibits MUC5AC gene expression, mucus production and secretion via regulation of NF-κB, STAT6 and HDAC2.7,4'-Dihydroxyflavone (7,4'-DHF) decreases phorbol 12-myristate 13-acetate (PMA) stimulated NCI-H292 human airway epithelial cell MUC5AC gene expression and mucus production with IC50 value of 1.4 µM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-123941
CAS No.: 2064175-32-0
Purity:  98.78%
Synonyms: dTAG-7
FKBP12 PROTAC dTAG-7 (dTAG-7) is a FKBP12 F36V PROTAC degrader. FKBP12 PROTAC dTAG-7 binds FKBP12 F36V and CRBN to form a complex, mediating degradation via the ubiquitin-proteasome system. FKBP12 PROTAC dTAG-7 mediates the degradation of FKBP12 F36V-tagged nuclear and cytoplasmic proteins, including BRD4, HDAC1, EZH2, MYC, PLK1, KRAS G12V, and antigen fusion proteins. FKBP12 PROTAC dTAG-7 enhances MHC class I antigen presentation. FKBP12 PROTAC dTAG-7 is applicable to leukemia-related research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100719
CAS No.: 849234-64-6
Purity:  98.74%
Target:  

HDAC HIV

Research Areas:  

Infection Cardiovascular Disease

BRD-6929 is a potent, selective brain-penetrant inhibitor of class I histone deacetylase HDAC1 and HDAC2 inhibitor with IC50 of 1 nM and 8 nM, respectively. BRD-6929 shows high-affinity to HDAC1 and HDAC2 with Ki of 0.2 and 1.5 nM, respectively. BRD-6929 can be used for mood-related behavioral model research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19747
CAS No.: 1429651-50-2
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HPOB is a highly potent and selective inhibitor of HDAC6 with an IC50 of 56 nM. HPOB displays >30 fold less potent against other HDACs. HPOB enhances the effectiveness of DNA-damaging anticancer agents in transformed cells but not normal cells. HPOB does not block the ubiquitin-binding activity of HDAC6 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16699
CAS No.: 1403783-31-2
Target:  

HDAC

Research Areas:  

Cancer

Nexturastat A is a potent, selective HDAC6 inhibitor. Nexturastat A has inhibitory for HDAC6 with an IC50 of 5 nM. Nexturastat A can be used for the research of multiple myeloma (MM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0106
CAS No.: 102767-28-2
Synonyms: UCB L059
Target:  

DNA Methyltransferase

Research Areas:  

Neurological Disease Cancer

Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N7676
CAS No.: 535-96-6
Marein has the neuroprotective effect due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway. Marein improves insulin resistance induced by high glucose in HepG2 cells through CaMKK/AMPK/GLUT1 to promote glucose uptake, through IRS/Akt/GSK-3β to increase glycogen synthesis, and through Akt/FoxO1 to decrease gluconeogenesis. Marein is a HDAC inhibitor with an IC50 of 100 μM. Marein has beneficial antioxidative, antihypertensive, antihyperlipidemic and antidiabetic effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-104008
CAS No.: 1609389-52-7
Purity:  99.66%
Target:  

HDAC

Research Areas:  

Others

ACY-957 is an orally active and selective inhibitor of HDAC1 and HDAC2, with IC50s of 7 nM, 18 nM, and 1300 nM against HDAC1/2/3, respectively, and shows no inhibition on HDAC4/5/6/7/8/9 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0494
CAS No.: 2438-72-4
Synonyms: Bufexamic acid
Target:  

HDAC Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

Bufexamac is a selective Ⅱb HDAC (HDAC6, HDAC10) and LTA4H dual inhibitor, with Kds of 0.53 µM and 0.22 µM for HDAC6 and HDAC10. Bufexamac is a nonsteroida anti-inflammatory drug .
loading...
    loading...